Meticulous Research® has released a comprehensive report titled, " North American molecular diagnostics market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User—Forecast to 2030." The report projects that the North America molecular diagnostics market will reach $18.13 billion by 2030, with a CAGR of 5.3% from 2023 to 2030.

Request For Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5642?

Growth Drivers

The market's growth is fueled by several factors. The increasing geriatric population is one significant driver, alongside the rising incidence of both communicable and non-communicable diseases. Technological advancements in molecular diagnostics and escalating healthcare expenditures are also contributing to market expansion. However, challenges such as unfavorable regulatory environments and high diagnostic test costs are hindering growth.

Opportunities and Challenges

The market holds promising opportunities, particularly with the growing emphasis on companion diagnostics and the rising trend of direct-to-consumer (DTC) genetic testing. Despite these opportunities, the shortage of skilled professionals presents a considerable challenge. Another significant trend is the integration of artificial intelligence and machine learning into molecular diagnostics, enhancing the precision and efficiency of testing.

Market Segmentation

The report segments the North America molecular diagnostics market into several categories. Products and services include kits and reagents, instruments, and software & services. Test types cover laboratory tests and point-of-care tests, while technologies span PCR, ISH, INAAT, microarrays, mass spectrometry, sequencing, and other methods. Applications range from infectious diseases and oncology to genetic testing, neurological diseases, and cardiovascular conditions. End users are categorized as hospitals & clinics, diagnostic laboratories, academic & research institutes, and others.

Market Insights

In 2023, the kits & reagents segment is anticipated to hold the largest market share. This dominance is driven by ongoing developments in diagnostic tests for infections and growing use of diagnostic platforms. Sequencing technology is projected to exhibit the highest CAGR, thanks to advancements that offer benefits over traditional PCR methods, such as the ability to detect unknown sequences through hypothesis-free approaches.

Laboratory vs. Point-of-Care Testing

Laboratory tests are expected to dominate the market in 2023 due to their higher accuracy and reliability compared to point-of-care tests. These tests offer greater sensitivity and specificity and can be applied across a range of diagnostic scenarios.

Oncology Segment Growth

The oncology segment is predicted to grow at the highest CAGR during the forecast period. Molecular diagnostics plays a crucial role in cancer detection and treatment, providing reliable screening and aiding in personalized treatment decisions.

Regional Insights

The U.S. is projected to account for the largest share of the North American market in 2023. The country's rapidly aging population, with a significant increase in those aged 65 and above, is driving the demand for molecular diagnostics. This demographic is more susceptible to various diseases, necessitating frequent diagnostic testing and contributing to market growth.

Buy Now: https://www.meticulousresearch.com/Checkout/62458641?

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:

Meticulous Research®

Email- sales@meticulousresearch.com

Contact Sales- +1-646-781-8004

Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous - research